Epstein-Barr Virus Vaccines

  • Check with publisher
  • Published date: November 30, 2018
    • Shirley, New York, United States

EBV vaccines to prevent primary infection or disease, or therapeutic vaccines to treat EBV malignancies have not been licensed. Most efforts to develop prophylactic vaccines have focused on EBV gp350, which is the major target of neutralizing antibody. A single phase 2 trial of an EBV gp350 vaccine has been reported; the vaccine reduced the rate of IM but not virus infection. The observation that infusion of EBV‐specific T cells can reduce disease due to Hodgkin lymphoma and nasopharyngeal carcinoma provides a proof of principle that a therapeutic vaccine for these and other EBV‐associated malignancies might be effective. Most therapeutic vaccines have targeted EBV LMP2 and EBV nuclear antigen. As EBV is associated with nearly 200,000 new malignancies each year worldwide, an EBV vaccine to prevent these diseases is needed.

Result 0 votes
Jerry Carter
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Design and Modification of Allogeneic Cell Vaccines

    Design and Modification of Allogeneic Cell Vaccines

    Molecular Biology Shirley (New York) November 30, 2018 Check with publisher

    Tumor cells are generally thought to be poorly immunogenic, although immunogenicity varies considerably between tumors of different backgrounds. Creative Biolabs is a world leader in the field of cancer vaccine development. We have a variety of strat...

  • Haloperidol [BSA]

    Haloperidol [BSA]

    Molecular Biology Shirley (New York) October 23, 2018 10.00 Dollar US$

    Haloperidol is a butyrophenone antipsychotic drug that has strong central antidopaminergic activity. It is used in the treatment of schizophrenia, acute psychotic states and delirium. https://www.creative-diagnostics.com/Haloperidol-BSA-254157-219.ht...

  • Halofuginone [BSA]

    Halofuginone [BSA]

    Molecular Biology Shirley (New York) October 23, 2018 10.00 Dollar US$

    Halofuginone is a coccidiostat used in veterinary medicine. It is a synthetic halogenated derivative of febrifugine, a natural quinazolinone alkaloid which can be found in the Chinese herb Dichroa febrifuga. Halofuginone inhibits the development of T...